New review provides insights on rates, predictors of relapse after surgery in Crohn's disease patients

NewsGuard 100/100 Score

Some patients with Crohn's disease, a chronic inflammatory disease that affects the lining of the digestive tract, require surgery to remove part or all of the large intestine; however, surgery does not cure the condition and many patients relapse after surgery. A new review and analysis of published studies provides insights on the rates of relapse and predictors of relapse among Crohn's disease patients who underwent surgical removal of the entire large intestine (total colectomy) and the creation of a permanent ileostomy (an opening in the abdominal wall).

In the analysis of 18 studies, the risk of recurrence was 28.0%, with a 5- and 10-year median cumulative rates of 23.5% and 40%, respectively. Patients with a history of Crohn's disease that affected the terminal ileum (the last part of the small intestine) were 3.2-times more likely to have recurrence than those without.

"Crohn's disease patients who are having total colectomy and ileostomy have a low risk of recurrence. These patients should be monitored, and treatment started in case of recurrence," said Dr Siddharth Singh, senior author of the Alimentary Pharmacology and Therapeutics article. "This is especially important for those patients who ever had Crohn's disease involving the last part of the small intestine."

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Google Gemini and Bard pass the ophthalmology board examination